Medicaid enrollment after liver transplantation: Effects of medicaid expansion

Dmitry Tumin, Don Hayes, W. Kenneth Washburn, Joseph D. Tobias, Sylvester M. Black – 6 May 2016 – Liver transplantation (LT) recipients in the United States have low rates of paid employment, making some eligible for Medicaid public health insurance after transplant. We test whether recent expansions of Medicaid eligibility increased Medicaid enrollment and insurance coverage in this population.

Perioperative prostaglandin e1 infusion in living donor liver transplantation: A double‐blind, placebo‐controlled randomized trial

Viju Kumar Bharathan, Biju Chandran, Unnikrishnan Gopalakrishnan, Christi Titus Varghese, Ramachandran N. Menon, Dinesh Balakrishnan, O. V. Sudheer, Puneet Dhar, Sudhindran Surendran – 6 May 2016 – The role of prostaglandin E1 (PGE1) infusion in improving early graft function has not been well defined, especially in the scenario of living donor liver transplantation (LDLT). We designed a randomized, double‐blind, placebo‐controlled trial to evaluate the role of perioperative PGE1 infusion in LDLT.

Vena cava encirclement predicts difficult native hepatectomy

Fabrizio Panaro, Gildas Boisset, Gérald Chanques, Boris Guiu, Astrid Herrero, Hassan Bouyabrine, Georges Philippe Pageaux, Karim Boudjema, Francis Navarro – 5 May 2016 – Recipient hepatectomy is a challenging liver transplantation (LT) procedure that has life‐threatening complications. The current predictive mortality clinic‐biological scores (Child/Model for End‐Stage Liver Disease [MELD]) do not take into consideration the recipient's liver anatomy.

Longterm clinical and radiological follow‐up of living liver donors

Sarwa Darwish Murad, Jeff L. Fidler, John J. Poterucha, William Sanchez, Sheila G. Jowsey, David Nagorney, Charles B. Rosen, Julie K. Heimbach – 4 May 2016 – Although short‐term risks of living donor hepatectomy have been well defined, little is known about the longterm impact. We aimed to perform a systematic follow‐up to screen for unanticipated health consequences of liver donation.

Outcomes of liver transplantation with liver grafts from pediatric donors used in adult recipients

Kristopher P. Croome, David D. Lee, Justin M. Burns, Hector Saucedo‐Crespo, Dana K. Perry, Justin H. Nguyen, C. Burcin Taner, Mayo Clinic Collaborative in Transplant Research and Outcomes – 4 May 2016 – Although there is an agreement that liver grafts from pediatric donors (PDs) should ideally be used for pediatric patients, there remain situations when these grafts are turned down for pediatric recipients and are then offered to adult recipients. The present study aimed to investigate the outcomes of using these grafts for liver transplantation (LT) in adult patients.

Subscribe to